Your browser doesn't support javascript.
loading
A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA).
Stewart, Grant D; Welsh, Sarah J; Ursprung, Stephan; Gallagher, Ferdia A; Jones, James O; Shields, Jacqui; Smith, Christopher G; Mitchell, Thomas J; Warren, Anne Y; Bex, Axel; Boleti, Ekaterini; Carruthers, Jade; Eisen, Tim; Fife, Kate; Hamid, Abdel; Laird, Alexander; Leung, Steve; Malik, Jahangeer; Mendichovszky, Iosif A; Mumtaz, Faiz; Oades, Grenville; Priest, Andrew N; Riddick, Antony C P; Venugopal, Balaji; Welsh, Michelle; Riddle, Kathleen; Hopcroft, Lisa E M; Jones, Robert J.
Afiliação
  • Stewart GD; University of Cambridge, Cambridge, UK. gds35@cam.ac.uk.
  • Welsh SJ; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. gds35@cam.ac.uk.
  • Ursprung S; University of Cambridge, Cambridge, UK.
  • Gallagher FA; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Jones JO; University of Cambridge, Cambridge, UK.
  • Shields J; University of Cambridge, Cambridge, UK.
  • Smith CG; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Mitchell TJ; University of Cambridge, Cambridge, UK.
  • Warren AY; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Bex A; MRC Cancer Unit, University of Cambridge, Cambridge, UK.
  • Boleti E; MRC Cancer Unit, University of Cambridge, Cambridge, UK.
  • Carruthers J; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
  • Eisen T; CRUK Cambridge Institute, Cambridge, UK.
  • Fife K; University of Cambridge, Cambridge, UK.
  • Hamid A; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Laird A; Wellcome Sanger Institute, Cambridge, UK.
  • Leung S; University of Cambridge, Cambridge, UK.
  • Malik J; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Mendichovszky IA; Royal Free London NHS Foundation Trust, London, UK.
  • Mumtaz F; Royal Free London NHS Foundation Trust, London, UK.
  • Oades G; Scottish Clinical Trials Research Unit, Public Health Scotland, Edinburgh, UK.
  • Priest AN; University of Cambridge, Cambridge, UK.
  • Riddick ACP; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Venugopal B; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Welsh M; Broomfield Hospital, Chelmsford, UK.
  • Riddle K; Western General Hospital, Edinburgh, UK.
  • Hopcroft LEM; Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Jones RJ; Western General Hospital, Edinburgh, UK.
Br J Cancer ; 127(6): 1051-1060, 2022 10.
Article em En | MEDLINE | ID: mdl-35739300
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombose / Carcinoma de Células Renais / Axitinibe / Neoplasias Renais Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombose / Carcinoma de Células Renais / Axitinibe / Neoplasias Renais Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article